Saturday - March 14, 2026

Schizophrenia Clinical Trial Pipeline Expands as 55+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | Sunovion Pharmaceuticals, AbbVie, Karuna Therapeutics

Schizophrenia – Pipeline Insight, 2026 DelveInsight’s latest report provides comprehensive insights about 55+ companies, such as Sunovion Pharmaceuticals, AbbVie, Karuna Therapeutics, Boehringer Ingelheim, Merck & Co., MapLight Therapeutics, Denovo Biopharma, Cyclerion Therapeutics, and others, developing several pipeline drugs in the … Continue reading

Autistic Disorder Pipeline Expands with 25+ Companies and 25+ Therapies in Development Across Clinical Stages, Reveals DelveInsight

Autistic Disorder Pipeline Key Autistic Disorder companies include AbbVie, Yamo Pharmaceuticals, Stalicla SA, Vanda Pharmaceuticals, Paxmedica, SciSparc, Scioto Biosciences, Hoffmann-La Roche, ACADIA Pharmaceuticals Inc., Neurotech International, Neuren Pharmaceuticals, MapLight Therapeutics, Jazz Pharmaceuticals, Axial Therapeutics Inc., and several others. DelveInsight’s “Autistic … Continue reading

Multiple Sclerosis Pipeline Expands with 80+ Drugs and 75+ Companies Advancing Next-Generation Therapies | DelveInsight

Multiple Sclerosis Pipeline Multiple Sclerosis companies include Novartis, Sanofi, Immunic, Biocad, Apimeds, Genentech (Roche), Merck, AB Science, Apurano Pharmaceuticals, Biogen, Tiziana Life Sciences, Worg Pharmaceuticals, Antisense Therapeutics, RemeGen, Atara Biotherapeutics, Contineum Therapeutics, Stem Cell Medicine Ltd., Ever Supreme Bio Technology … Continue reading

HER2-Negative Metastatic Breast Cancer Market Expected to Transform Significantly Through 2034, According to DelveInsight | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene

HER2-Negative Metastatic Breast Cancer Market Major companies actively participating in the HER2-Negative Metastatic Breast Cancer market include Genentech, Inc., AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai Inc., Novartis Pharmaceuticals, Adagene Inc., Jiangsu HengRui Medicine Co., Ltd., Pfizer, … Continue reading

Atopic Dermatitis Pipeline Expands with 120+ Therapies and 100+ Companies Advancing Novel Treatments, Reveals DelveInsight Report

Atopic Dermatitis Pipeline Atopic Dermatitis companies including Pfizer, Kymera Therapeutics, BenevolentAI, AstraZeneca, Qurient, Sterna Biologicals, Vanda Pharmaceuticals, and Arcutis Biotherapeutics, among others are actively developing treatment options for atopic dermatitis. The “Atopic Dermatitis Pipeline Insight, 2026” report by DelveInsight presents … Continue reading

Chronic Spontaneous Urticaria Pipeline Expands with 25+ Therapies and 20+ Companies Advancing Next-Generation Treatments by 2026 | DelveInsight

Chronic Spontaneous Urticaria Pipeline Chronic Spontaneous Urticaria Companies include Novartis, Hangzhou Highlightll Pharmaceutical Co., Ltd, Celldex Therapeutics, Jemincare, Yuhan Corporation, United BioPharma, Septerna, Recludix Pharma, among others. DelveInsight’s report titled “Chronic Spontaneous Urticaria Pipeline Insight 2026” offers an extensive evaluation … Continue reading

AI Platforms for Rapid Fashion Design and E‑commerce Video: Emerging Tools Empower Independent Designers and Small Teams

Independent fashion designers and small creative teams are embracing a new era where AI platforms are transforming how apparel is designed, visualized, and marketed online. Leading solutions like Style3D AI, ZMO AI, Runway, Pika Labs, Browzwear, TUKAcad, and Adobe Firefly … Continue reading

Parkinson’s Disease Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | FAScinate Therapeutics, Hoffmann-La Roche, Pharma Two B Ltd., Neuropore Therapies, Olatec Therapeutics, UCB Bio

The Key Parkinson’s Disease Companies in the market include – FAScinate Therapeutics, Hoffmann-La Roche, Pharma Two B Ltd., Neuropore Therapies, Inc., Olatec Therapeutics, UCB Biopharma, Vaxxinity, Modag, Peptron, Kissei Pharmaceutical, Cerevel Therapeutics, and others.   DelveInsight’s “Parkinson’s Disease Market Insights, … Continue reading